CytoVeris Appoints Scott Flora, Medical Device Executive, as Strategic Advisor

FARMINGTON, CONN.  NOVEMBER 23, 2020

CytoVeris Inc., an emerging company formed with the vision to change the paradigm in cancer surgery through the introduction of optical-based “guided surgical tools,” today announced the appointment of Mr. Scott Flora to its Advisory team. Currently Board Chair for Palliare Ltd, Conventus Orthopaedics and New View Surgical, Mr. Flora brings to CytoVeris significant knowledge and more than 40 years of medical device experience in implantable devices and surgical instruments.

“We are excited to have Scott join us as a strategic advisor,” said Dr. Alan Kersey, President and CEO of CytoVeris. “We are eager to leverage his extensive industry experience and surgical device domain expertise to pursue our mission of disrupting the current paradigm of breast cancer surgery and improve the lives of cancer patients,”

Mr. Flora has previously held several leadership roles including Interim President and CEO of Invuity, Executive Director of Conventus Orthopaedics, President and CEO of OmniGuide Surgical, President of Covidien’s Surgical Device Group and President of Smith & Nephew Orthopedic Reconstruction. He has also served on three public company boards including Invuity, MAKO Surgical and Tengion.

“Our advisors provide invaluable guidance and direction as we pursue our mission at CytoVeris,” commented Mr. Patrick Curry, Chief Operating Officer and Vice President of Finance of CytoVeris. “We are thrilled to welcome Mr. Flora, an accomplished business professional, to this esteemed group and look forward to his guidance.”

Scroll to Top

“CYTOVERIS NAMED "MURPHY'S INNOVATOR OF THE MONTH"

CytoVeris is a medical device company developing optical smart cancer imaging technologies designed to improve the clinical outcomes of patients undergoing certain cancer removal procedures by using enhanced clinical decision-making during surgery.